SCHEMBL8204925

SCHEMBL8204925

CC(=O)[C@@H](NC(=O)OC1CCCC1)C(C)C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.47
TSHR P16473 3/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 3/20 0.40
ALDH1A1 P00352 2/20 0.40
HDAC4 P56524 1/20 0.38
HDAC1 Q13547 1/20 0.38
CYP19A1 P11511 1/20 0.36
ALOX15 P16050 1/20 0.35
HSD17B10 Q99714 1/20 0.35
IDO1 P14902 1/20 0.35
MEN1 O00255 1/20 0.35
CYP1A2 P05177 1/20 0.35
MAPT P10636 1/20 0.35
KMT2A Q03164 1/20 0.35
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4C Q08493 1/20 0.34
PDE4D Q08499 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12599181 0.93 EPHX1 (0.38) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL3054649 0.88 SMN1; SMN2 (0.54) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL889324 0.88 EPHX1 (0.46) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL3054655 0.88 SMN1; SMN2 (0.54) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL15058144 0.86 EPHX1 (0.53) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL4739321 0.86 TSHR (0.55) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL8682268 0.86 EPHX1 (0.53) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL8922057 0.85 KAT2B (0.35) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL8919103 0.85 KAT2B (0.35) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2
SCHEMBL15058009 0.84 SMN1; SMN2 (0.50) EPHX1TSHRCYP3A4CYP2C19SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9156818-B2 Hepatitis C virus inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-10-13 US disclosed
WO-2008033389-A2 MACROCYCLIC HCV INHIBITORS AND THEIR USES NOVARTIS AG (CH) 2008-03-20 WO disclosed